trial · primary record
Vasopressin
Cardiac Disease
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 153 |
| Primary completion | 2024-12-31 |
| Primary endpoint | mPAP-to-MAP Ratio |
| Registry ID | NCT04501861 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:44.231Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04501861
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.